Adult Dosing

Acne vulgaris

>12yrs

• Apply once daily qhs

Note:

• Avoid the eyes, lips, and mucous membranes
• Avoid oral, ophthalmic, or intravaginal use

Pediatric Dosing

• Safety and effectiveness in pediatric patients have not been established

• Treatment of acne vulgaris in patients 12 yrs

• Hypersensitivity to any of the ingredients of the product
• Regional enteritis
• Ulcerative colitis
• History of antibiotic associated colitis

• N/A

Renal Dose Adjustment

• Renal impairment: No dose adjustments

Hepatic Dose Adjustment

• Hepatic impairment: No dose adjustments

See Supplemental Patient Information

• Clostridium difficile associated diarrhea which may vary in severity from mild to fatal colitis, has been reported with use of all antibiotics; discontinue therapy on occurrence of significant diarrhea, bloody diarrhea, colitis and pseudomembranous colitis
• Avoid exposure to sunlight, including sunlamps during use of gel
• Weather extremes, such as wind or cold may irritate the patients

Cautions: Use cautiously in:

• Considerable sun exposure due to occupation
• Sensitivity to the sun
• Sunburn

Supplemental Patient Information

• Advise patients with sunburn to avoid use of the product until fully recovered because of heightened susceptibility to sunlight
• Encourage the daily use of sunscreen products and proper apparel (hat) in patients

Pregnancy Category:C

Breastfeeding: Safety unknown; clindamycin can cause adverse effects on the breastfed infant's gastrointestinal flora. Monitor infants for diarrhea, candidiasis or colitis. Literature on the use of topical tretinoin during breastfeeding is unavailable. Due to poor absorption on topical application considered as a low risk to the nursing infant. Ensure that the infant's skin does not come into direct contact with the treated areas of skin. Apply only water-miscible cream products to the breast because ointments may expose the infant to high levels of mineral paraffins via licking. This information is based upon LactMed database (available at http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT last accessed 9 December 2010). Unknown whether clindamycin/tretinoin is excreted in human milk on topical application. Oral and parenteral uses of clindamycin have been reported to appear in breast milk. Exhibits potential for causing serious adverse reactions in nursing infants. Manufacturer advises caution and discontinue nursing or drug taking into account the importance of drug to the mother

• GI: Pseudomembranous colitis
• DERM: Dryness, irritation, exfoliation, erythema, pruritus, dermatitis, sunburn, scaling, stinging, burning, photosensitivity

clindamycin

• Lincomycin antibiotic; binds to 50S ribosomal subunit and inhibits bacterial protein synthesis
• Systemically absorbed
• Metabolized by liver; CYP450: unknown
• Excreted in urine and feces
• Half-life: 2.4 hrs

Tretinoin

• Retinoid; decreases cohesiveness of follicular epithelial cells with decreased microcomedone formation, stimulates mitotic activity and increases turnover of follicular epithelial cells causing extrusion of the comedones
• Minimal systemic absorption
• Metabolized by liver; CYP450: unknown
• Excreted in urine and feces
• Half-life: 0.5-2 hrs

US Trade Name(s)

• Veltin
• Ziana

US Availability

Veltin (clindamycin/tretinoin)

• GEL: 1.2%/0.025%

Ziana (clindamycin/tretinoin)

• GEL: 1.2%/0.025%

Canadian Trade Name(s)

• N/A

Canadian Availability

• N/A

UK Trade Name(s)

• N/A

UK Availability

• N/A

Australian Trade Name(s)

• N/A

Australian Availability

• N/A

Dermatologic

Dermatologic Topical Agents

Anti-Acne Agents

Pricing data from www.DrugStore.com in U.S.A.

• Ziana 1.2-0.025 % GEL [Tube] (MEDICIS)
  60 % = $472.13
  180 % = $1347.81
• Ziana 1.2-0.025 % GEL [Tube] (MEDICIS)
  30 % = $248.44
  90 % = $730.82
• Veltin 1.2-0.025 % GEL [Tube] (GLAXO SMITH KLINE)
  30 % = $165.98
  90 % = $479.95

Warning: This pricing information is subject to change at the sole discretion of DS Pharmacy. For the most current and up-to-date pricing information, please visit drugstore.com.